Clinical Trial Update: Autologous Bone Marrow Mononuclear Cell Transplantation in Treating Type 2 Diabetes Mellitus [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for autologous bone marrow mononuclear cell transplantation in type 2 diabetes mellitus, completed Phase 1/Phase 2 studies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Autologous bone marrow mononuclear cell transplantation

Snippet

Sponsor: Peking University Aerospace Center Hospital | Conditions: Type 2 Diabetes Mellitus | Phase 1, Phase 2 | Status: COMPLETED